Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Filana Therapeutics
AddedFeb 19, 2024
UpdatedJul 4, 2026
Filana Therapeutics

Filana Therapeutics

Public

Cassava Sciences, a Texas-based American pharmaceutical company, founded in 1998.

HQ
Austin, TX, US
Founded
1998
Overview
Compare
Fundraising
Employees

Cassava Sciences, a Texas-based American pharmaceutical company, was founded in 1998 by Remi Barbier. The company focuses on developing innovative treatments for neurodegenerative diseases, particularly Alzheimer's disease. Their core mission is to improve patient outcomes through cutting-edge research and development.

Cassava Sciences has made significant strides in Alzheimer's research, with notable advancements in clinical trials for their lead drug candidate, simufilam. Their work has garnered attention from the scientific community and investors, contributing to the ongoing fight against neurodegenerative disorders.

Filana Therapeutics - Similar Companies

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

Denali Therapeutics logo

Denali Therapeutics

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Cognitive Synergy logo

Cognitive Synergy

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

Sonexa Therapeutics logo

Sonexa Therapeutics

Cass Pharmaceuticals logo

Cass Pharmaceuticals

casspharma.com

Intellect Neurosciences logo

Intellect Neurosciences

Cajal Neuroscience logo

Cajal Neuroscience

cajalneuro.com

Afraxis logo

Afraxis

Caden Biosciences logo

Caden Biosciences

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

Casma Therapeutics logo

Casma Therapeutics

casmatx.com

Chase Therapeutics logo

Chase Therapeutics

Gilead Sciences logo

Gilead Sciences

gilead.com

Filana Therapeutics - Quick Facts

Who are Filana Therapeutics' competitors?

Companies similar to Filana Therapeutics include CuraSen Therapeutics, Denali Therapeutics, NeuroGenetic Pharmaceuticals and Cognitive Synergy.

When was Filana Therapeutics founded?

Filana Therapeutics was founded in 1998.

Where is Filana Therapeutics' headquarters located?

Filana Therapeutics' headquarters is located in Austin, TX, US.

When was Filana Therapeutics' last funding round?

Filana Therapeutics' most recent funding round was for $50M (USD) in November 2022.

How much has Filana Therapeutics raised to-date?

As of Nov 18, 2022, Filana Therapeutics has raised a total of $256.9M (USD).

How many employees does Filana Therapeutics have?

Filana Therapeutics has 26 employees as of Feb 6, 2024.

Filana Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Unique IDs
  • secCik: 0001069530
  • ticker: FLNA
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research